A detailed history of Lindenwold Advisors transactions in Stevanato Group S.P.A. stock. As of the latest transaction made, Lindenwold Advisors holds 11,930 shares of STVN stock, worth $245,280. This represents 0.12% of its overall portfolio holdings.

Number of Shares
11,930
Previous 10,515 13.46%
Holding current value
$245,280
Previous $192,000 23.96%
% of portfolio
0.12%
Previous 0.1%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$17.98 - $22.02 $25,441 - $31,158
1,415 Added 13.46%
11,930 $238,000
Q2 2024

Aug 13, 2024

BUY
$16.93 - $31.33 $7,025 - $13,001
415 Added 4.11%
10,515 $192,000
Q1 2024

May 09, 2024

BUY
$25.34 - $34.28 $255,934 - $346,228
10,100 New
10,100 $324,000
Q3 2023

Oct 19, 2023

BUY
$26.91 - $35.49 $3,229 - $4,258
120 Added 1.73%
7,055 $209,000
Q2 2023

Aug 07, 2023

BUY
$25.15 - $32.86 $174,415 - $227,884
6,935 New
6,935 $224,000

Others Institutions Holding STVN

About Stevanato Group S.p.A.


  • Ticker STVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 264,700,000
  • Market Cap $5.44B
  • Description
  • Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machine...
More about STVN
Track This Portfolio

Track Lindenwold Advisors Portfolio

Follow Lindenwold Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindenwold Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Lindenwold Advisors with notifications on news.